SUMMARY
Bleeding and clotting in patients with vascular anomalies can come with
significant morbidity and mortality. Therefore, it is essential to have
an experienced multidisciplinary team which includes a hematologist
well-versed in management of coagulopathy in patients with vascular
anomalies. Most recommendations are based on small studies, case series
and institutional experience. As the field grows and advances, larger
prospective studies are needed to identify those patients who are at
risk of coagulopathy and establish evidence-based guidelines for
evaluation and treatment.